# Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD)

> **NCT04256538** · — · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 179 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04256538
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-15
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04256538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04256538, "Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04256538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*